Inflammatix Investors

19 investors on Angel Roster list Inflammatix in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Inflammatix can appear together.

Investors listed
19
With verified email
47%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 19 Inflammatix investors

The most complete profiles first. Showing 19 of 19.

  • Kanu GulatiVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AHealth CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Verified email available

  • Rajesh SwaminathanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Verified email available

  • Alex MorganVerified

    Venture Capital · United States

    Health CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Verified email available

  • Brian ByunVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Verified email available

  • Shaan GandhiVerified

    Venture Capital · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Verified email available

  • Sven StrohbandVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Verified email available

  • Todd McIntyreVerified

    Venture Capital, Investor · United States

    Series AHealth CareArtificial Intelligence (AI)Information Technology (IT)Bioinformatics

    Portfolio: Biolinq, Winterlight Labs, AmacaThera, HepaTx and 4 more

    Verified email available

  • Alice Brooks

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Contact details available

  • Connor McDermott

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Kristina Simmons

    Venture Capital, Founder, Private Equity Firm · United States

    SeedPre-SeedHealth CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 89 more

    Contact details available

  • Sharon Kedar, CFA

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Michael BanksVerified

    Venture Capital · United States

    Health CareArtificial Intelligence (AI)Information Technology (IT)Bioinformatics

    Portfolio: Biolinq, Winterlight Labs, AmacaThera, HepaTx and 4 more

    Verified email available

  • Paul WuVerified

    Venture Capital · United States

    Health CareArtificial Intelligence (AI)Information Technology (IT)Bioinformatics

    Portfolio: Biolinq, Winterlight Labs, AmacaThera, HepaTx and 4 more

    Verified email available

  • Bruce Armstrong

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Contact details available

  • Keith Janosky

    Venture Capital · United States

    Health CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Contact details available

  • Mike Rubin, MD, PhD, CFA

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Patrick Smerkers

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Samantha Shalom

    Venture Capital · United States

    Health CareHospitalsAlternative MedicineWomen Founded

    Portfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more

    Contact details available

  • Vinod Khosla

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesE-commerceMessaging

    Portfolio: Caption Health, Volterra, Quell, Imply and 88 more

    Contact details available

Frequently asked questions

How many Inflammatix investors are on Angel Roster?

Angel Roster lists 19 Inflammatix investors. 9 of them (47%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (19), Private Equity Firms (11) and Founder-Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Inflammatix investors invest in?

Among those that list a stage, the most common are Series B (3), Seed (3) and Series A (2).

Where are Inflammatix investors based?

Most are based in the United States (19).

Which companies have Inflammatix investors backed?

The most-backed portfolio companies among them are Scipher Medicine (16), Clear Labs (10), Ellipsis Health (10), Backpack (10) and Heyday (10).

How do I contact Inflammatix investors?

Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.